ArticleThe Journal of clinical investigation2020

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.

Melinda A Biernacki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.